PepGen: Audience

PepGen is focused on developing a new generation of disease-modifying therapies targeting serious genetic neuromuscular and neurological diseases. Utilizing their proprietary Enhanced Delivery Oligonucleotide (EDO) platform, they aim to create effective treatments that address the root causes of these conditions.